190 related articles for article (PubMed ID: 29350080)
1. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
2. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia.
Mozziconacci MJ; Liberatore C; Grignani F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
Leukemia; 1999 Jun; 13(6):862-8. PubMed ID: 10360373
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia.
Borrow J; Solomon E
Baillieres Clin Haematol; 1992 Oct; 5(4):833-56. PubMed ID: 1339190
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.
Yin CC; Jain N; Mehrotra M; Zhagn J; Protopopov A; Zuo Z; Pemmaraju N; DiNardo C; Hirsch-Ginsberg C; Wang SA; Medeiros LJ; Chin L; Patel KP; Ravandi F; Futreal A; Bueso-Ramos CE
J Natl Compr Canc Netw; 2015 Jan; 13(1):19-22. PubMed ID: 25583766
[TBL] [Abstract][Full Text] [Related]
5. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.
Chen Y; Pan M; Chen L; Peng M; Liu Z; Fang Y; Du Y; Yang Y; Xu P
Ann Hematol; 2024 Apr; 103(4):1181-1185. PubMed ID: 38294534
[TBL] [Abstract][Full Text] [Related]
7. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Yang X; Zhang R; Zhang Z
Ann Hematol; 2022 Sep; 101(9):2101-2102. PubMed ID: 35704083
[No Abstract] [Full Text] [Related]
8. Successful treatment of acute promyelocytic leukemia with a t(X;17)(p11.4;q21) and BCOR-RARA fusion gene.
Ichikawa S; Ichikawa S; Ishikawa I; Takahashi T; Fujiwara T; Harigae H
Cancer Genet; 2015 Apr; 208(4):162-3. PubMed ID: 25790901
[No Abstract] [Full Text] [Related]
9. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts.
Park TS; Lee ST; Kim JS; Song J; Lee KA; Kim SJ; Seok YM; Lee HJ; Han JH; Kim JK; Lee EY; Choi JR
Cancer Genet Cytogenet; 2009 Jan; 188(1):48-51. PubMed ID: 19061780
[TBL] [Abstract][Full Text] [Related]
10. [Retinoic acid receptor alpha gene in t (15; 17) APL].
Takashima T; Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1363-8. PubMed ID: 1325570
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
12. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
[TBL] [Abstract][Full Text] [Related]
13. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.
Shimomura Y; Mitsui H; Yamashita Y; Kamae T; Kanai A; Matsui H; Ishibashi T; Tanimura A; Shibayama H; Oritani K; Kuyama J; Kanakura Y
Cancer Sci; 2016 Aug; 107(8):1165-8. PubMed ID: 27193600
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
16. The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Swaney EM; Chattopadhyay A; Abecassis I; Rush EA; Redner RL
Leuk Lymphoma; 2016 Aug; 57(8):1933-7. PubMed ID: 26754533
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
18. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
19. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
20. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
